Literature DB >> 28792261

pH-sensitive pHLIP® coated niosomes.

Mohan C Pereira1, Monica Pianella2, Da Wei1, Anna Moshnikova1, Carlotta Marianecci2, Maria Carafa2, Oleg A Andreev1, Yana K Reshetnyak1.   

Abstract

Nanomedicine is becoming very popular over conventional methods due to the ability to tune physico-chemical properties of nano vectors, which are used for encapsulation of therapeutic and diagnostic agents. However, the success of nanomedicine primarily relies on how specifically and efficiently nanocarriers can target pathological sites to minimize undesirable side effects and enhance therapeutic efficacy. Here, we introduce a novel class of targeted nano drug delivery system, which can be used as an effective nano-theranostic for cancer. We formulated pH-sensitive niosomes (80-90 nm in diameter) using nonionic surfactants Span20 (43-45 mol%), cholesterol (50 mol%) and 5 mol% of pH (Low) insertion peptide (pHLIP) conjugated with DSPE lipids (DSPE-pHLIP) or hydrophobic fluorescent dye, pyrene, (Pyr-pHLIP). In coating of niosomes, pHLIP was used as an acidity sensitive targeting moiety. We have demonstrated that pHLIP coated niosomes sense the extracellular acidity of cancerous cells. Intravenous injection of fluorescently labeled (R18) pHLIP-coated niosomes into mice bearing tumors showed significant accumulation in tumors with minimal targeting of kidney, liver and muscles. Tumor-targeting niosomes coated with pHLIP exhibited 2-3 times higher tumor uptake compared to the non-targeted niosomes coated with PEG polymer. Long circulation time and uniform bio-distribution throughout the entire tumor make pHLIP-coated niosomes to be an attractive novel delivery system.

Entities:  

Keywords:  Drug delivery; fluorescence imaging; targeting tumor acidity

Year:  2017        PMID: 28792261      PMCID: PMC5658010          DOI: 10.1080/09687688.2017.1342969

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  54 in total

1.  Enhanced oral bioavailability of griseofulvin via niosomes.

Authors:  Pratap S Jadon; Virendra Gajbhiye; Rajesh S Jadon; Kavita R Gajbhiye; Narayanan Ganesh
Journal:  AAPS PharmSciTech       Date:  2009-10-24       Impact factor: 3.246

2.  Nonionic surfactant-based vesicular system for transdermal drug delivery.

Authors:  Saeed Ghanbarzadeh; Arash Khorrami; Sanam Arami
Journal:  Drug Deliv       Date:  2014-01-08       Impact factor: 6.419

3.  Proniosomes as a carrier system for transdermal delivery of tenoxicam.

Authors:  H O Ammar; M Ghorab; S A El-Nahhas; I M Higazy
Journal:  Int J Pharm       Date:  2010-12-01       Impact factor: 5.875

4.  In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.

Authors:  Abbas Pardakhty; Jaleh Varshosaz; Abdolhossein Rouholamini
Journal:  Int J Pharm       Date:  2006-08-12       Impact factor: 5.875

Review 5.  Extracellular acidity as favouring factor of tumor progression and metastatic dissemination.

Authors:  L Calorini; S Peppicelli; F Bianchini
Journal:  Exp Oncol       Date:  2012-07

6.  Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture.

Authors:  C J Chu; J Dijkstra; M Z Lai; K Hong; F C Szoka
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 7.  pH-sensitive liposomes--principle and application in cancer therapy.

Authors:  H Karanth; R S R Murthy
Journal:  J Pharm Pharmacol       Date:  2007-04       Impact factor: 3.765

8.  Studies on a high encapsulation of colchicine by a niosome system.

Authors:  Yongmei Hao; Fenglin Zhao; Na Li; Yanhong Yang; Ke'an Li
Journal:  Int J Pharm       Date:  2002-09-05       Impact factor: 5.875

Review 9.  Causes and consequences of increased glucose metabolism of cancers.

Authors:  Robert J Gillies; Ian Robey; Robert A Gatenby
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

Review 10.  Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.

Authors:  Charlene M Dawidczyk; Luisa M Russell; Peter C Searson
Journal:  Front Chem       Date:  2014-08-25       Impact factor: 5.221

View more
  5 in total

1.  Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery.

Authors:  Federica Rinaldi; Patrizia N Hanieh; Elena Del Favero; Valeria Rondelli; Paola Brocca; Mohan C Pereira; Oleg A Andreev; Yana K Reshetnyak; Carlotta Marianecci; Maria Carafa
Journal:  Nanoscale Res Lett       Date:  2018-12-04       Impact factor: 4.703

Review 2.  Nanoarchitectonics of Multifunctional Niosomes for Advanced Drug Delivery.

Authors:  Denitsa B Momekova; Viliana E Gugleva; Petar D Petrov
Journal:  ACS Omega       Date:  2021-12-06

Review 3.  Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.

Authors:  Bwalya A Witika; Kokoette E Bassey; Patrick H Demana; Xavier Siwe-Noundou; Madan S Poka
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

4.  Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.

Authors:  Xixi Hu; Jun Zhang; Lulu Deng; Hao Hu; Junjie Hu; Guohua Zheng
Journal:  AAPS PharmSciTech       Date:  2021-03-10       Impact factor: 3.246

Review 5.  Lipid-Based Nanovesicular Drug Delivery Systems.

Authors:  Tania Limongi; Francesca Susa; Monica Marini; Marco Allione; Bruno Torre; Roberto Pisano; Enzo di Fabrizio
Journal:  Nanomaterials (Basel)       Date:  2021-12-14       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.